Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D08WQM
|
||||
| Former ID |
DNC002796
|
||||
| Drug Name |
O-Sialic Acid
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [551374] | ||
| Structure |
|
Download2D MOL |
|||
| Formula |
C11H19NO9
|
||||
| Canonical SMILES |
CC(=O)NC1C(CC(OC1C(C(CO)O)O)(C(=O)O)O)O
|
||||
| InChI |
1S/C11H19NO9/c1-4(14)12-7-5(15)2-11(20,10(18)19)21-9(7)8(17)6(16)3-13/h5-9,13,15-17,20H,2-3H2,1H3,(H,12,14)(H,18,19)/t5-,6+,7+,8+,9+,11?/m0/s1
|
||||
| InChIKey |
SQVRNKJHWKZAKO-LUWBGTNYSA-N
|
||||
| PubChem Compound ID | |||||
| PubChem Substance ID | |||||
| Target and Pathway | |||||
| Target(s) | P-selectin | Target Info | Inhibitor | [551374] | |
| Neuraminidase | Target Info | Inhibitor | [551374] | ||
| E-selectin | Target Info | Inhibitor | [551374] | ||
| Liver carboxylesterase | Target Info | Inhibitor | [551374] | ||
| WikiPathways | Human Complement System | ||||
| Spinal Cord Injury | |||||
| Cell surface interactions at the vascular wallWP2806:Human Complement System | |||||
| TNF alpha Signaling Pathway | |||||
| Cell surface interactions at the vascular wallWP2884:NRF2 pathway | |||||
| Nuclear Receptors Meta-Pathway | |||||
| Heroin metabolism | |||||
| Irinotecan Pathway | |||||
| Fluoropyrimidine Activity | |||||
| Phase I biotransformations, non P450 | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.